National Cancer Institute; Notice of Closed Meetings, 61309-61310 [2017-27939]
Download as PDF
Federal Register / Vol. 82, No. 247 / Wednesday, December 27, 2017 / Notices
Dated: December 20, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–27937 Filed 12–26–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
daltland on DSKBBV9HB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant and/or contract
proposals applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
and/or contract proposals applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI SPORE
II Review.
Date: January 29–30, 2018.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Klaus B. Piontek, Ph.D.,
Scientific Review Officer, Research Program
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W612,
Bethesda, MD 20892–9750, 240–276–5413,
klaus.piontek@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Cachexia Therapy and Local Delivery of
Chemopreventive Agents.
Date: February 8, 2018.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W030, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Bethesda, MD 20892–9750,
240–276–5460, jfang@mail.nih.gov.
VerDate Sep<11>2014
21:43 Dec 26, 2017
Jkt 244001
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–6:
Modified RNA and Oncosomes.
Date: February 14, 2018.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W114, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W114, Bethesda, MD 20892–
9750, 240–276–6371, decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Program Project I.
Date: February 20–21, 2018.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Klaus B. Piontek, Ph.D.,
Scientific Review Officer, Research Program
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W612,
Bethesda, MD 20892–9750, 240–276–5413.
klaus.piontek@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Imaging
Radiation and Immunotherapies.
Date: February 20–21, 2018.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Jun Fang, Ph.D., Scientific
Review Officer, Research Technology and
Contract Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W246, Bethesda, MD 20892–9750,
240–276–5460, jfang@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Biological
Comparisons in Patient-Derived Models of
Cancer.
Date: February 23, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W236, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Robert S. Coyne, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W236, Bethesda, MD
20892–9750, 240–276–5120, coynes@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–2:
Software Tools & Sensors for the Cancer
Therapeutics.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
61309
Date: February 28–March 1, 2018.
Time: 5:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Washington DC/Rockville
Hotel, 1750 Rockville Pike, Bethesda, MD
20852.
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH 9609 Medical Center
Drive, Room 7W260, Bethesda, MD 20892–
9750, 240–276–5856, nadeem.khan@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–1 for
Provocative Questions.
Date: March 1, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Byeong-Chel Lee, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH 9609, Medical Center Drive,
Room 7W238, Bethesda, MD 20892–9750,
240–276–7755, byeong-chel.lee@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, NCI
Clinical and Translational Exploratory/
Developmental Studies.
Date: March 1–2, 2018.
Time: 5:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Zhiqiang Zou, MD, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W242, Bethesda, MD
20892–9750, 240–276–6372, zouzhiq@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI R03 &
Clinical and Translational R21: SEP–1A.
Date: March 29, 2018.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W260, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities National,
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W260, Bethesda, MD 20892–
9750, 240–276–5856, nadeem.khan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
E:\FR\FM\27DEN1.SGM
27DEN1
61310
Federal Register / Vol. 82, No. 247 / Wednesday, December 27, 2017 / Notices
Cancer Control, National Institutes of Health,
HHS)
Dated: December 20, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–27939 Filed 12–26–17; 8:45 am]
Lane, MSC 9823, Bethesda, MD 20892–9823,
240) 669–5044, nv19q@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 21, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–27938 Filed 12–26–17; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HOMELAND
SECURITY
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
daltland on DSKBBV9HB2PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Coast Guard
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Partnerships for
Development of Clinically Useful Diagnostics
for Antimicrobial-Resistant Bacteria (R01).
Date: January 18, 2018.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Lynn Rust, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
room 3G42A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5069,
lrust@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implementation Cooperative Agreement
(U01).
Date: January 19, 2018.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Nancy VazquezMaldonado, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3F52B National
Institutes of Health/NIAID, 5601 Fishers
VerDate Sep<11>2014
21:43 Dec 26, 2017
Jkt 244001
[Docket No. USCG–2017–1009]
Commercial Fishing Safety Advisory
Committee
U.S. Coast Guard, Department
of Homeland Security.
ACTION: Request for applications.
AGENCY:
The U.S. Coast Guard seeks
applications for membership on the
Commercial Fishing Safety Advisory
Committee. The Commercial Fishing
Safety Advisory Committee provides
advice and makes recommendations to
the Coast Guard and the Department of
Homeland Security on various matters
relating to the safe operation of
commercial fishing industry vessels.
Both positions were previously
advertised under Docket No. USCG–
2017–0829 but no applications for either
of the two positions were received.
DATES: Completed applications should
be submitted to the U.S. Coast Guard on
or before February 26, 2018.
ADDRESSES: Applicants should send a
cover letter expressing interest in an
appointment to the Commercial Fishing
Safety Advisory Committee that also
identifies which membership category
the applicant is applying under, along
with a resume detailing the applicant’s
experience via one of the following
methods:
• By Email: Jonathan.G.Wendland@
uscg.mil, Subject line: The Commercial
Fishing Safety Advisory Committee.
• By Mail: Commandant (CG–CVC–
3)/CFSAC, Attn: Mr. Jonathan
Wendland, U.S. Coast Guard, 2703
Martin Luther King Ave. SE, Stop 7501,
Washington, DC 20593–7501.
FOR FURTHER INFORMATION CONTACT: Mr.
Jonathan Wendland, Alternate
Designated Federal Officer of the
Commercial Fishing Safety Advisory
Committee, 202–372–1245 or
Jonathan.G.Wendland@uscg.mil.
SUMMARY:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
The
Commercial Fishing Safety Advisory
Committee is a federal advisory
committee which operates under the
provisions of the Federal Advisory
Committee Act, (Title 5, U.S.C.
Appendix). The U.S. Coast Guard
chartered the Commercial Fishing
Safety Advisory Committee to provide
advice on issues related to the safety of
commercial fishing industry vessels
regulated under Chapter 45 of title 46,
United States Code, which includes
uninspected fish catching vessels, fish
processing vessels, and fish tender
vessels. (See Title 46 U.S.C. 4508.)
The Commercial Fishing Safety
Advisory Committee meets at least once
a year. It may also meet for other
extraordinary purposes. Its
subcommittees or working groups may
communicate throughout the year to
prepare for meetings or develop
proposals for the committee as a whole
or to address specific tasks.
Each member serves for a term of
three years. An individual may be
appointed to a term as a member more
than once, but not more than two terms
consecutively. All members serve at
their own expense and receive no salary
or other compensation from the Federal
Government, although travel
reimbursement and per diem may be
provided for called meetings.
The U.S. Coast Guard will consider
applications for two (02) positions that
will be vacant on January 2018 in the
following categories:
(a) An individual who represents the
general public, a marine surveyor who
provides services to vessels to which
Chapter 45 of Title 46 U.S.C. applies
(one position);
(b) An individual who represents
manufacturers of equipment for vessels
to which Chapter 45 of Title 46, U.S.C.
applies (one position);
If you are selected as a member from
the general public, you will be
appointed and serve as a Special
Government Employee as defined in
Section 202(a) of Title 18, U.S.C.
Applicants for appointment as a Special
Government Employee are required to
complete a Confidential Financial
Disclosure Report (OGE Form 450). The
U.S. Coast Guard may not release the
reports or the information in them to the
public except under an order issued by
a Federal court or as otherwise provided
under the Privacy Act (5 U.S.C. 552a).
Only the Designated U.S. Coast Guard
Ethics Official or his or her designee
may release a Confidential Financial
Disclosure Report. Applicants can
obtain this form by going to the website
of the Office of Government Ethics
(www.oge.gov), or by contacting the
SUPPLEMENTARY INFORMATION:
E:\FR\FM\27DEN1.SGM
27DEN1
Agencies
[Federal Register Volume 82, Number 247 (Wednesday, December 27, 2017)]
[Notices]
[Pages 61309-61310]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-27939]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant and/or contract proposals applications
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant and/or
contract proposals applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI SPORE II Review.
Date: January 29-30, 2018.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Klaus B. Piontek, Ph.D., Scientific Review
Officer, Research Program Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W612, Bethesda, MD 20892-9750, 240-276-5413,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Cachexia Therapy and Local Delivery of Chemopreventive
Agents.
Date: February 8, 2018.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-6: Modified RNA and Oncosomes.
Date: February 14, 2018.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W114, Bethesda, MD 20892-9750, 240-276-6371,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Program Project I.
Date: February 20-21, 2018.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Klaus B. Piontek, Ph.D., Scientific Review
Officer, Research Program Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W612, Bethesda, MD 20892-9750, 240-276-5413.
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Imaging Radiation and Immunotherapies.
Date: February 20-21, 2018.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Biological Comparisons in Patient-Derived Models of Cancer.
Date: February 23, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W236, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Robert S. Coyne, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W236, Bethesda, MD 20892-9750, 240-276-5120, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-2: Software Tools & Sensors for the Cancer Therapeutics.
Date: February 28-March 1, 2018.
Time: 5:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hilton Washington DC/Rockville Hotel, 1750 Rockville
Pike, Bethesda, MD 20852.
Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH 9609 Medical
Center Drive, Room 7W260, Bethesda, MD 20892-9750, 240-276-5856,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-1 for Provocative Questions.
Date: March 1, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH 9609, Medical
Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-7755,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel, NCI Clinical and Translational Exploratory/Developmental
Studies.
Date: March 1-2, 2018.
Time: 5:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, North Bethesda, MD 20852.
Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W242, Bethesda, MD 20892-9750, 240-276-6372, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI R03 & Clinical and Translational R21: SEP-1A.
Date: March 29, 2018.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W260, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities National, Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W260, Bethesda, MD 20892-9750, 240-276-5856,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399,
[[Page 61310]]
Cancer Control, National Institutes of Health, HHS)
Dated: December 20, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-27939 Filed 12-26-17; 8:45 am]
BILLING CODE 4140-01-P